Institutional investors purchased a net $3.5 million shares of SRPT during the quarter ended December 2012, and now own 69.31% of the total float, a percentage that is typical for companies in the Biotechnology industry.
| Other institutional | 51.00% |
| Mutual fund holders | 18.31% |
| Individual stakeholders | 0.67% |